Logo image of ESRX

EXPRESS SCRIPTS HLDG CO (ESRX) Stock Price, Forecast & Analysis

USA - NASDAQ:ESRX - US30219G1085

92.33
-3.47 (-3.62%)
Last: 12/20/2018, 8:21:55 PM
92.51
+0.18 (+0.19%)
After Hours: 12/20/2018, 8:21:55 PM

ESRX Key Statistics, Chart & Performance

Key Statistics
Market Cap52.06B
Revenue(TTM)101.35B
Net Income(TTM)4.90B
Shares563.86M
Float563.86M
52 Week High101.73
52 Week Low66.93
Yearly Dividend0
Dividend Yield0%
EPS(TTM)8.58
PE10.76
Fwd PE9.72
Earnings (Next)N/A N/A
IPON/A
Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A


ESRX short term performance overview.The bars show the price performance of ESRX in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 -5 10 15

ESRX long term performance overview.The bars show the price performance of ESRX in the last 1, 2 and 3 years. 1 year 2 years 3 years 5 10 15 20

The current stock price of ESRX is 92.33 null. In the past month the price decreased by -3.11%. In the past year, price increased by 23.88%.

EXPRESS SCRIPTS HLDG CO / ESRX Daily stock chart

ESRX Latest News, Press Relases and Analysis

About ESRX

Company Profile

Express Scripts Holding Company puts medicine within reach of tens of millions of people by aligning with plan sponsors, taking bold action and delivering patient-centered care to make better health more affordable and accessible. Headquartered in St. Louis, Express Scripts provides integrated pharmacy benefit management services, including network-pharmacy claims processing, home delivery pharmacy care, specialty pharmacy care, specialty benefit management, benefit-design consultation, drug utilization review, formulary management, and medical and drug data analysis services. Express Scripts also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services.

Company Info

EXPRESS SCRIPTS HLDG CO

ONE EXPRESS WAY

SAINT LOUIS MO 63121

CEO: Timothy Wentworth

Phone: 314-996-0900

EXPRESS SCRIPTS HLDG CO / ESRX FAQ

What does EXPRESS SCRIPTS HLDG CO do?

Express Scripts Holding Company puts medicine within reach of tens of millions of people by aligning with plan sponsors, taking bold action and delivering patient-centered care to make better health more affordable and accessible. Headquartered in St. Louis, Express Scripts provides integrated pharmacy benefit management services, including network-pharmacy claims processing, home delivery pharmacy care, specialty pharmacy care, specialty benefit management, benefit-design consultation, drug utilization review, formulary management, and medical and drug data analysis services. Express Scripts also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services.


What is the current price of ESRX stock?

The current stock price of ESRX is 92.33 null. The price decreased by -3.62% in the last trading session.


What is the dividend status of EXPRESS SCRIPTS HLDG CO?

ESRX does not pay a dividend.


How is the ChartMill rating for EXPRESS SCRIPTS HLDG CO?

ESRX has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


Where is EXPRESS SCRIPTS HLDG CO (ESRX) stock traded?

ESRX stock is listed on the Nasdaq exchange.


What is the market capitalization of ESRX stock?

EXPRESS SCRIPTS HLDG CO (ESRX) has a market capitalization of 52.06B null. This makes ESRX a Large Cap stock.


ESRX Technical Analysis

ChartMill assigns a technical rating of 3 / 10 to ESRX. When comparing the yearly performance of all stocks, ESRX is one of the better performing stocks in the market, outperforming 93.2% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

ESRX Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to ESRX. While ESRX belongs to the best of the industry regarding profitability, there are concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ESRX Financial Highlights

Over the last trailing twelve months ESRX reported a non-GAAP Earnings per Share(EPS) of 8.58. The EPS increased by 25.44% compared to the year before.


Industry RankSector Rank
PM (TTM) 4.83%
ROA 8.84%
ROE 23.82%
Debt/Equity 0.63
Chartmill High Growth Momentum
EPS Q2Q%27.89%
Sales Q2Q%3.56%
EPS 1Y (TTM)25.44%
Revenue 1Y (TTM)1.81%

ESRX Forecast & Estimates


Analysts
AnalystsN/A
Price TargetN/A
EPS Next Y27.89%
Revenue Next YearN/A

ESRX Ownership

Ownership
Inst Owners84.87%
Ins Owners0.09%
Short Float %N/A
Short RatioN/A